Ident. | Authors (with country if any) | Title |
---|
001360 (2012) |
Xiang Qiu [République populaire de Chine] ; Chao Hong [République populaire de Chine] ; Yue Li [République populaire de Chine] ; Wanrong Bao [République populaire de Chine] ; Xiao-Ming Gao [République populaire de Chine] | Calreticulin as a hydrophilic chimeric molecular adjuvant enhances IgG responses to the spike protein of severe acute respiratory syndrome coronavirus |
001425 (2011) |
Danijela Koppers-Lalic [Pays-Bas] ; Rob C. Hoeben [Pays-Bas] | Non‐human viruses developed as therapeutic agent for use in humans |
001714 (2006) |
Yasuko Tsunetsugu-Yokota [Japon] ; Kazuo Ohnishi [Japon] ; Toshitada Takemori [Japon] | Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine |
001720 (2006) |
Louise Lohse [Danemark] ; Jens Nielsen [Danemark] ; Lis Eriksen [Danemark] | Long‐term treatment of pigs with low doses of monoclonal antibodies against porcine CD4 and CD8 antigens |
001777 (2005) |
Patrick C. Y. Woo [Hong Kong] ; Yi Huang [Hong Kong] ; Susanna K. P. Lau [Hong Kong] ; Hoi-Wah Tsoi [Hong Kong] ; Kwok-Yung Yuen [Hong Kong] | In Silico Analysis of ORF1ab in Coronavirus HKU1 Genome Reveals a Unique Putative Cleavage Site of Coronavirus HKU1 3C‐Like Protease |
001926 (2000) |
P. Roccabianca [Italie] ; J. C. Woo [États-Unis] ; P. F. Moore [États-Unis] | Characterization of the diffuse mucosal associated lymphoid tissue of feline small intestine |
001937 (1999) |
Douglas S. Zatechka Jr. [États-Unis] ; Nagendra R. Hegde [États-Unis] ; Kandasamy Hariharan [États-Unis] ; S. Srikumaran [États-Unis] | Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1 |
001944 (1999) |
Peter J. Koetters ; Loubna Hassanieh ; Stephen A. Stohlman ; Thomas Gallagher ; Michael M. C. Lai | Mouse Hepatitis Virus Strain JHM Infects a Human Hepatocellular Carcinoma Cell Line |
001959 (1998) |
Z. Zidek [République tchèque] ; K. Mašek [République tchèque] | Review Article Erratic behavior of nitric oxide within the immune system: illustrative review of conflicting data and their immunopharmacological aspects |
001961 (1998) |
Per Johan Klasse [Royaume-Uni] ; Romke Bron [Royaume-Uni] ; Mark Marsh [Royaume-Uni] | Mechanisms of enveloped virus entry into animal cells |
001991 (1997) |
Vesna Barac-Latas [Croatie] ; Gerda Suchanek [Autriche] ; Helene Breitschopf [Autriche] ; Albert Stuehler [Allemagne] ; Helmut Wege [Allemagne] ; Hans Lassmann [Autriche] | Patterns of oligodendrocyte pathology in coronavirus‐induced subacute demyelinating encephalomyelitis in the lewis rat |
001A08 (1996) |
Dana M. Grzybicki [États-Unis] ; Kyubum Kwack [États-Unis] ; Stanley Perlman [États-Unis] ; Sean P. Murphy [États-Unis] | Nitric oxide synthase Type II expression by different cell types in MHV-JHM encephalitis suggests distinct roles for nitric oxide in acute versus persistent virus infection |
001A61 (1994) |
Benjamin M. Segal [États-Unis] ; Cedric S. Raine [États-Unis] ; Dale E. Mcfarlin [États-Unis] ; Rhonda R. Voskuhl [États-Unis] ; Henry F. Mcfarland [États-Unis] | Experimental allergic encephalomyelitis induced by the peptide encoded by exon 2 of the MBP gene, a peptide implicated in remyelination |
001A97 (1993) |
Christopher W. Olsen [États-Unis] | A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination |
001B36 (1992) |
Kinjiro Morimoto [Japon] ; Ya-Jin Ni [Japon] ; Akihiko Kawai [Japon] | Syncytium formation is induced in the murine neuroblastoma cell cultures which produce pathogenic type G proteins of the rabies virus |
001B49 (1992) |
Ronald S. Murray [États-Unis] ; Guang-Yun Cai [États-Unis] ; Kristen Hoel [États-Unis] ; J.-Y. Zhang [États-Unis] ; Kenneth F. Soike [États-Unis] ; Gary F. Cabirac [États-Unis] | Coronavirus infects and causes demyelination in primate central nervous system |
001B76 (1991) |
Matsubara Yutaka [Japon] ; Watanabe Rihito [Japon] ; Taguchi Fumihiro [Japon] | Neurovirulence of six different murine coronavirus JHMV variants for rats |
001B96 (1991) |
Neal S. Burres [États-Unis] ; Dustan A. Barber [États-Unis] ; Sarath P. Gunasekera [États-Unis] ; Linus L. Shen [États-Unis] ; Jacob J. Clement [États-Unis] | Antitumor activity and biochemical effects of topsentin |
001C20 (1990) |
Monique Dubois-Dalcq [États-Unis] ; Regina Armstrong [États-Unis] | The cellular and molecular events of central nervous system remyelination |
001C40 (1989) |
Klaus Eichmann [Allemagne] | Foreword |
001C74 (1988) |
Paul. T. Massa [Allemagne] ; Helmut Wege [Allemagne] ; Volker Ter Meulen [Allemagne] | Growth pattern of various JHM coronavirus isolates in primary rat glial cell cultures correlates with differing neurotropism in vivo |
001C90 (1988) |
Moses Rodriguez [États-Unis] | Mechanisms of Virus‐Induced Demyelination and Remyelination |
001C99 (1988) |
| Abstracts of Papers Presented at the Session of the Virology Section of the Deutsche Gesellschaft für Hygiene und Mikrobiologie, Martinsried, March 25–28, 1987 |
001D07 (1987) |
Stephen W. Barthold [États-Unis] ; Abigail L. Smith [États-Unis] | Response of genetically susceptible and resistant mice to intranasal inoculation with mouse hepatitis virus JHM |
001D15 (1987) |
Roelf Datema [Suède] ; Sigvard Olofsson [Suède] ; Pedro A. Romero [Suède, Canada] | Inhibitors of protein glycosylation and glycoprotein processing in viral systems |
001D25 (1987) |
R. Dörries [Allemagne] ; R. Watanabe [Allemagne] ; H. Wege [Allemagne] ; V. Ter Meulen [Allemagne] | Analysis of the intrathecal humoral immune response in Brown Norway (BN) rats, infected with the murine coronavirus JHM |
001D77 (1985) |
P. Massa [Allemagne] ; H. Wege [Allemagne] ; R. Watanabe [Allemagne] ; V. Ter Heulen [Allemagne] | Abstract 43. Neural cell cultures as a tool in analyzing neurovirulence and persistence of viruses |
001D78 (1985) |
R. Rubenstein [États-Unis] ; R. W. Price [États-Unis] | Abstract 42. Metabolic alterations of HSV-1-infected neurons: studies using the PC12 cell as a model system |
001D80 (1985) |
O. Sorensen [Canada] ; S. Beushausen [Canada] ; M. Coulter-Mackie [Canada] ; S. Dales [Canada] | Abstract 36. In vivo and in vitro models of demyelinating disease: factors influencing the disease process caused by coronavirus infection of the rat |
001E02 (1984) |
M. Koga [Allemagne] ; H. Wege [Allemagne] ; V. Ter Meulen [Allemagne] | SEQUENCE OF MURINE CORONAVIRUS JHM INDUCED NEUROPATHOLOGICAL CHANGES IN RATS |
001E24 (1983) |
A. Zurbriggen [Suisse] ; M. Vandevelde [Suisse] | Canine distemper virus-induced glial cell changes in vitro |
001E26 (1983) |
| Abstracts of Papers Presented at the 8th Workshop of the Virology Section of the Deutsche Gesellschaft für Hygiene und Mikrobiologie, Würzburg, March 17–19, 1983 |
001E45 (1982) |
G. Trautwein | Immunkomplex‐Krankheiten bei Mensch und Tieren |
001E46 (1982) |
Mauro C. Dal Canto [États-Unis] ; Stanley G. Rabinowitz [États-Unis] | Experimental models of virus‐induced demyelination of the central nervous system |
001E58 (1981) |
Steve Cheley [Canada] ; Robert Anderson [Canada] ; Margaret J. Cupples [Canada] ; Edwin C. M. Lee Chan [Canada] ; Vincent L. Morris [Canada] | Intracellular murine hepatitis virus-specific RNAs contain common sequences |
001F26 (1976) |
William E. Stewart Ii [États-Unis] ; Leo S. Lin [États-Unis] | Antiviral activities of interferons |